Professor Stephen Burgess
(he/him/his)About Professor Stephen Burgess
I am a Group Leader at the MRC Biostatistics Unit.
I completed a BA and MMath (Part III) in Mathematics at the University of Cambridge. I then studied for a PhD in the MRC Biostatistics Unit, Cambridge, from 2008-2011 working on methods for Mendelian randomization analysis under the supervision of Simon Thompson. I joined the Cardiovascular Epidemiology Unit in the Department of Public Health and Primary Care of the University of Cambridge in 2011. In 2013, I was awarded a Wellcome Trust entry-level fellowship (Sir Henry Wellcome Post-doctoral Fellowship) to continue theoretical and applied work in the field of Mendelian randomization. In 2017, I moved to the MRC Biostatistics Unit on a Wellcome Trust/Royal Society intermediate fellowship (Sir Henry Dale Fellowship) to establish a research group in the MRC Biostatistics Unit, where I am now a Group Leader. In 2023, I was given a Career Development Award by the Wellcome Trust to continue work in this area. I now lead a small team of researchers split between the MRC Biostatistics Unit and the Cardiovascular Epidemiology Unit.
I am always open to requests for collaboration, either on theoretical or applied Mendelian randomization projects.
Research Interests
My main area of research is causal inference and specifically methods for Mendelian randomization: the use of genetic variants to understand whether putative risk factors are causally related to specific disease outcomes (target validation).
Mendelian Randomization book
The book “Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation”, by Stephen Burgess and Simon G Thompson was published by Chapman and Hall in 2015. A second edition of the book is due to be published in mid-2021. More details are available at the book website: www.mendelianrandomization.com.
A short course which roughly follows the content of the book is run twice a year, once in the spring and again the late autumn.
Publications
Showing 1 to 10 of 640 publications
Elucidating the proteomic pathways linking childhood body mass index with type 2 diabetes: a Mendelian randomization and recall-by-genotype study.
Authors: S Chen, Y Liang, S Luo, J Zheng, S Yoshiji, GM Power, Z Xu, S Burgess, BJ Cowling, HS Lam, AM Li, GM Leung, CM Schooling, SL Au Yeung
Published:
Journal: Int J Epidemiol
DOI: 10.1093/ije/dyag165
No genetic evidence for an association of apolipoprotein A-I with cardiovascular outcomes at different LDL cholesterol levels: drug-target Mendelian randomization analyses.
Authors: S Luo, Y Ai, S Burgess, SL Au Yeung, M Ala-Korpela
Journal: Atherosclerosis
DOI: 10.1016/j.atherosclerosis.2026.120815
Assessing the causal effects of environmental tobacco smoke exposure: a meta-analytic Mendelian randomization study.
Authors: B Woolf, S Rajasundaram, J Pott, D Gill, HM Sallis, S Burgess, MR Munafò
Published:
Journal: Nicotine Tob Res
DOI: 10.1093/ntr/ntag047
Causal Inference in Clinical Research: A Primer.
Authors: NZ Bashir, M Kebschull, S Burgess, GG Nascimento
Published:
Journal: J Periodontal Res
DOI: 10.1111/jre.70142
Statin Use and Genetically Predicted HMG-CoA Reductase Inhibition in Relation to Clonal Hematopoiesis.
Authors: PR Carter, M Gozdecka, S Wen, PM Quirós, SM Lockhart, M Dudek, L Bond, G Richenberg, SC Larsson, D Bromage, J Mitchell, B Huntly, P Libby, MCH Clarke, M Fabre, GS Vassiliou, S Burgess, SP Kar
Published:
DOI: 10.64898/2026.07.08.26357595
Glucagon-like peptide-1 receptor activation and mental health: a drug-target mendelian randomization study.
Authors: G Yang, S Burgess, CM Schooling
Published:
Journal: Transl Psychiatry
DOI: 10.1038/s41398-026-04244-7
Randomized, controlled, and real.
Authors: A Al-Kassab-Córdova, S Burgess, N Bashir
Published:
Journal: J Clin Epidemiol
DOI: 10.1016/j.jclinepi.2026.112414
Blood Manganese and Risk of Squamous Cell Carcinomas of the Head and Neck.
Authors: B Clay, N Bashir, S Burgess, P Carter
Published:
Journal: JAMA Otolaryngol Head Neck Surg
DOI: 10.1001/jamaoto.2026.1749
Comparison of methods for assessing effects of risk factors on disease progression in Mendelian randomization under index event bias.
Authors: L Zhang, IA Higgins, Q Dai, A Gkatzionis, J Quistrebert, N Bashir, G Dharmalingam, P Bhatnagar, D Gill, Y Liu, S Burgess
Published:
Journal: Am J Hum Genet
DOI: 10.1016/j.ajhg.2026.06.004
Figure S1 from PCSK9 and Breast Cancer Survival: A Mendelian Randomization Study
Authors: J Pott, AM Mason, V Salo, J Kettunen, S Burgess
Published:
DOI: 10.1158/1055-9965.32742228